- Home
- KXIN vs SNPX Comparison
KXIN vs SNPX Comparison
Compare KXIN & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- SNPX
- Stock Information
- Founded
- KXIN 2015
- SNPX 2012
- Country
- KXIN China
- SNPX United States
- Employees
- KXIN N/A
- SNPX N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- SNPX Medicinal Chemicals and Botanical Products
- Sector
- KXIN Consumer Discretionary
- SNPX Health Care
- Exchange
- KXIN Nasdaq
- SNPX Nasdaq
- Market Cap
- KXIN 3.1M
- SNPX 3.7M
- IPO Year
- KXIN N/A
- SNPX N/A
- Fundamental
- Price
- KXIN $1.76
- SNPX $2.57
- Analyst Decision
- KXIN
- SNPX Strong Buy
- Analyst Count
- KXIN 0
- SNPX 1
- Target Price
- KXIN N/A
- SNPX $14.00
- AVG Volume (30 Days)
- KXIN 727.4K
- SNPX 13.5K
- Earning Date
- KXIN 11-26-2019
- SNPX 11-12-2024
- Dividend Yield
- KXIN N/A
- SNPX N/A
- EPS Growth
- KXIN N/A
- SNPX N/A
- EPS
- KXIN N/A
- SNPX N/A
- Revenue
- KXIN $12,679,000.00
- SNPX N/A
- Revenue This Year
- KXIN N/A
- SNPX N/A
- Revenue Next Year
- KXIN N/A
- SNPX N/A
- P/E Ratio
- KXIN N/A
- SNPX N/A
- Revenue Growth
- KXIN N/A
- SNPX N/A
- 52 Week Low
- KXIN $1.66
- SNPX $2.32
- 52 Week High
- KXIN $64.80
- SNPX $8.78
- Technical
- Relative Strength Index (RSI)
- KXIN 36.41
- SNPX 40.67
- Support Level
- KXIN $1.66
- SNPX $2.52
- Resistance Level
- KXIN $1.96
- SNPX $2.80
- Average True Range (ATR)
- KXIN 0.15
- SNPX 0.21
- MACD
- KXIN 0.18
- SNPX -0.02
- Stochastic Oscillator
- KXIN 19.63
- SNPX 7.35
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.